Article Text


303 High dose Intravenous Melatonin for Augmentation of Hypothermic Neuroprotection Leads to Hypotension
  1. M Ezzati,
  2. S Faulkner,
  3. K Broad,
  4. NJ Robertson
  1. Institute for Women’s Health, University College London, London, UK


Background Therapeutic hypothermia provides neuroprotection in infants with moderate to severe neonatal encephalopathy, however further treatments are necessary as hypothermic neuroprotection is not absolute.

Aim To assess the effect on mean arterial blood pressure of high dose intravenous melatonin (20, 10, 5 mg/kg) administered 10 minutes after hypoxia-ischemia.

Methods Male piglets underwent a hypoxic-ischemic insult and were then commenced on different doses of intravenous melatonin. Physiological measures such as mean arterial blood pressure and heart rate were measured. Hypothermia (core temperature 33.5°C) was induced at 2–26h after hypoxia-ischemia.

Results 20mg/kg melatonin induced a rapid reduction in blood pressure beginning at 1 hour following its administration (1–3h post administration; mean arterial blood pressure was reduced from 60 to 24mm Hg). 10mg/kg induced a gradual reduction in blood pressure at 1 hour post administration (1–4h post administration; mean arterial blood pressure was reduced from 55 to 31mm Hg). However treatment with either 0 or 5 mg/kg melatonin had no effect on mean arterial blood pressure.

Abstract 303 Figure 1

Effect of different Melatonin doses on mean BP

Conclusion Intravenous doses of melatonin (>5mg/kg) lead to hypotension following a hypoxic-ischemic insult when combined with hypothermia. Future pre-clinical studies of augmented hypothermic neuroprotection should be conducted using melatonin doses of 5mg/kg or less.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.